Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Therapeutic Solutions International Identifies and Files Patent on Novel Mechanism of Action of Its FDA Phase III Cleared JadiCell™ Treatment of COVID-19 and Delta Variant
Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today novel data and filing of a […]
Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines Using Synthetic Biology
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the […]
Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
BioNTech Plans Malaria Vaccine Based on Revolutionary Covid-19 Jab Technology
BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the launch of its Malaria project, which aims to […]
Diamyd Medical Secures Precision Medicine Patent for Prevention and Treatment of Autoimmune Diabetes
The European Patent Office has informed Diamyd Medical that the Company’s patent application regarding prevention […]
First Treatment Approved in England for Advanced Bile Duct Cancer
The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]
NHS England Announces New Innovative Medicines Fund to Fast-track Promising New Drugs
NHS patients are set to benefit from early access to potentially life-saving new medicines, including cutting-edge gene therapies, […]
New Data for Roche’s Hemlibra Reinforce Safety Profile in People with Haemophilia A
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from the final analysis of the […]
Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market
A vaccination refers to a biological product that is utilized to provide acquired immunity against a […]
Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma
AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more